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In this paper the DNA sequence of the cloned hlyC gene from E. coli 2001 is presented. The gene encodes 
a protein of 20 kDa which is able to activate the 107 kDa polypeptide encoded by hlyA. This gives rise 
to a haemolytically active protein which differs from the inactive form in stability and by its migration when 
analysed by polyacrylamide gel electrophoresis under non-denaturing conditions. We also show that the 
inactive form is secreted in the presence of the transport functions hlyB and hlyD. This result rules out any 
role for the h/yC gene product in the transport of HlyA across the inner membrane 
Hemolysin secretion Post-translational modification hlyC sequence 
1. INTRODUCTION 
The haemolysin determinant is composed of an 
approx. 7 kb region encoding 4 genes. A 3 kb 
region encoding hlyC and h/yA determines the syn- 
thesis of a haemolytically active protein whilst a 
contiguous 4 kb region encodes hlyB and hlyD 
(nomenclature adopted from [ 11, corresponding to 
hlyBa and hlyBb, respectively) which are essential 
for export of the haemolysin to the culture medium 
[2-41. 
Goebel and co-workers [5] proposed that the 
hlyC gene is involved in a proteolytic cleavage of 
the 107 kDa polypeptide encoded by hlyA and the 
concomitant transport of a haemolytically active 
58 kDa derivative across the inner membrane. 
From the periplasm, it was proposed that this pro- 
tein is then transported across the outer membrane 
by the export functions encoded by hlyB and hlyD. 
In contrast, we have shown that the extracellular 
form of the haemolysin is a 107 kDa polypeptide 
[3,6]. In addition we now show for the first time 
that some form of post-translational modification 
* To whom reprint requests should be sent 
of haemolysin is effected by hlyC which leads to 
the activation of the 107 kDa haemolysin. We also 
show that this protein is transported to the medium 
in the complete absence of HlyC. 
2. MATERIALS AND METHODS 
2.1. strains 
The laboratory Escherichiu coli K12 strain 
MC4100 rpsL, ara139, A(lacIPOZA) ~169, thi was 
used in all of these studies. The plasmid pLG570 
contains the haemolytic determinant from LE2001 
isolated as described in [3]. The plasmids pLG575 
and pLG583 have been described elsewhere 
(Mackman et al., submitted). Plasmid pUC12 has 
been described by Messing [7]. 
2.2. Media 
Cultures were grown in rich medium (Luria 
broth) in the presence of 10 mM calcium chloride. 
2.3. Gene expression system 
The in vitro transcription-translation procedure 
using plasmid DNA templates was carried out as in 
181. 
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Fig. 1. Restriction endonuclease map and genetic organization of the Hly determinant LE2001. pLG570 containing the 
hly determinant from a human isolate E. coli LE2001 is shown with the hIyC and htyA cistrons placed according to 
transposon mapping and complementation analysis (Mackman et al., submitted). pLG571 and pLG577 are also shown. 
A restriction endonuclease map of pLG577 was obtained byTartia1 digestion of end-labelled DNA as described [14]. 
The 1.4 kb PvuII fragment containing the hlyC gene was cloned into the SmaI site of pUC12 to form the recombinant 
plasmid pLG591. The construction of plasmid pLG575 containing the export functions and plasmid pLG583 containing 
hlyA is described elsewhere (Mackman et al., submitted). (E) EcoRI, (B) BumHI, (Bg) BgflI, (H) HindIII. 
2.4. DNA sequencing 
This was performed according to the Sanger 
technique using the Ml3 mpWmp9/mp18 system 
[9] as described in [lo]. 
2.5. Stability of the 107 kDa protein 
The stability of [35S]methionine-labelled 
107 kDa protein was measured by spectroscopic 
scanning of autoradiograms as in [l 11. 
107- 100 
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3. RESULTS 
3.1. Cloning of hlyC and identification of its gene 
product 
A restriction map of the plasmid pLG570 con- 
taining hly determinant from the human 
haemolytic strain LE2001 [3] is shown in fig.1. 
Fig.1 also shows further detailed restriction site 
analysis of the region surrounding hlyC. A 
previous complementation analysis localised 2 
genes hlyA and h/yC required for intracellular 
haemolytic activity in pLG570. To characterise the 
hlyC gene, the EcoRI and the BgflI-BamHI 
- 
1 2 3 
Fig.2. Plasmid DNA of pLG570, and the subclones 
pLG571 and pLG577 were used to programme an in 
vitro coupled transcription-translation system and 
proteins labelled with [“Slmethionine. These proteins 
were visualised by autoradiography after SDS-PAGE 
(11% acrylamide). Track 1, pLG577; track 2, pLG57 1; 
track 3, pLG570. Note the 14 kDa polypeptide in track 
2 is not well resolved using an 11% gel. Molecular 
masses are given in kDa. 
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LEHLYC :ATGAATATAAACAAACCATTAGAGATTCTTGGGCATGTATCCTG 
70 80 90 100 110 ,110 
LEHLYC 
LEHLYC :GCTAACCAATATGTTTTATTAACCCGGGA 
ALaAsnGLnTyrVaLLeuLeuThrArgAs 
190 200 210 220 230 240 
LEHLYC :AATTTAAGTTTAGAAAATGAAATTAAATATCTTAATGATGTTACCTCATT 
AsnLeuSerLeuGLuAsnGLuILeLysTyrLeuAsnAspVaLThrSerLe 
250 260 270 280 290 300 
LEHLYC :GACTGGACTTCAGGTGATCGTAAATGGTTCATTGACTGGATTGCTCCTTTCGGGGATAAC 
AspTrpThrSerGLyAspArgLysTrpPheILeAspTrpILeALaProPheGLyAspAsn 
3.10 320 330 340 350 360 
LEHLYC 
LEHLYC 
LyGLyLysILeAspLys 
490 500 510 520 530 540 
snPheSerLeuThrGLv** 
550 560 570 580 590 600 
LEHLYC 
ThrALaGLnILeLysSerTh 
640 c 650 
LEHLYC :TCAGCAGGACAAAGCACGAAAGATGCATTAAAAAAAGCAGCAGAGCAAACCCGAAAT 
SerALaGLyGLnSerThrLysAspACaLeuLysLysACaALaGLuGLnThrArgAsp 
Fig.3. Nucleotide and amino acid sequences of the hlyC gene and the 5’-end of the hlyA gene of the chromosomal 
haemolytic determinant LE2001. The sequences were compared with the sequences of the hlyC gene [ 121 and the 5 ’ -end 
of the hlyA gene [5] of the haemolytic determinant of animal origin coded by the plasmid pHly152. The position of 
the BarnHI site shown in fig.1 is indicated. 
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fragments of pLG570 were cloned into the EcoRI 
and the BarnHI sites of pACYC184 to form the 
recombinant plasmids pLG577 and pLG57 1, 
respectively (fig. 1). Plasmid pLG577 complements 
the h/y_4 (pLG583) and the export functions h&E, 
hlyD (pLG575) in vivo to produce haemolytic 
clones whilst pLG571 fails to produce haemolytic 
clones under these conditions. The analysis of the 
proteins synthesised in vitro with these recombi- 
nant plasmids is shown in fig.2. Plasmid pLG577, 
directed the synthesis of a 20 kDa protein cor- 
responding to the hlyC gene product. In addition, 
this fragment directed the synthesis of an 82 kDa 
polypeptide which appears to be a protein fusion 
containing part of the Cat protein and the N- 
terminal region of the 107 kDa polypeptide. In 
contrast, pLG571 failed to direct the synthesis of 
a 20 kDa protein but a new 14 kDa protein was 
detected which appears to be a truncated form of 
HlyC, resulting from cloning the BgflI-BamHI 
fragment. In consequence a 1.4 kb PvuII fragment 
containing the BumHI site identified above was in- 
serted into the SmaI site of pUC12. The resulting 
recombinant plasmid pLG591, cotransformed with 
pLG583, which encodes hly_4, resulted in the pro- 
duction of internal haemolytic activity demon- 
strating the presence of a functional hlyC gene pre- 
sent in the PvuII fragment. 
Inspection of the amino acid sequence of HlyC in- 
dicates the presence of a hydrophobic domain be- 
tween residues 27 and 48. However, preliminary 
localisation studies suggest hat the polypeptide is 
not an integral membrane protein and the polypep- 
tide is identical in size when synthesised in vitro 
and in vivo demonstrating that proteolytic process- 
ing of the N-terminal region does not take place. 
3.3. The role of hlyC in the production of active 
haemolysin 
We have constructed subclones in which h/y_4 is 
fully expressed (as determined by the use of HlyA 
antiserum) from the tet promoter in the absence of 
hlyC (Mackman et al., submitted). This indicates 
that HlyC is not required at the translational evel 
for the expression of hlyA. 
To test the role of HlyC in the export of HlyA 
a strain was constructed carrying the plasmid 
3.2. Sequence of the hlyC gene 107u 
The relevant portion of the 1.4 kb PvuII frag- 
ment surrounding the BamHI site was sequenced 
by the Sanger technique. Few differences were 
found from the published hlyC sequence [12] and 
therefore only a low percentage of the DNA was 
sequenced from both strands. Fig.3 shows the 
DNA sequence and the predicted amino acid con- 
tent encoded by hlyC. This is also compared with 
the hlyC gene encoded by the haemolytic plasmid 
pHly152 of animal origin [12]. The two genes are 
remarkably homologous with 97% of the DNA se- 
quence being conserved and 92% of the amino acid 
sequence similarly conserved. The most important 
difference in the DNA sequence from Hly 2001 
results in the presence of an additional C 
nucleotide at position 493 which gives a different 
reading frame for the C-terminal region compared 
with the HlyC protein of pHly152. This results in 
the HlyA protein translation initiation codon being 
immediately after the stop codon of the hlyC gene. 
Fig.4. Comparison of the modified and the unmodified 
form of the haemolysin. Supernatant samples from late 
exponentially growing cultures were analysed by SDS- 
PAGE (11% acrylamide) in A or under non-denaturing 
gel electrophoresis conditions (11% acrylamide) in the 
absence of SDS, B. Track 1, non-haemolytic, 
unmodified form (e) of HlyA produced by MC4100, 
pLG575 + pLG583; track 2, the modified form (c) 
produced by MC4100, pLG570. 
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pLG583 (hlyA), together with pLG575 which en- 
codes all the export functions. Although such 
clones are completely non-haemolytic substantial 
amounts of a 107 kDa protein were found in the 
medium (fig.4). The identity of this protein as the 
haemolysin was confirmed by precipitation with 
antibody (not shown). Therefore, although the 
HlyC protein is required for activation of the HlyA 
protein it is not required for its secretion to the 
medium. When the two protein products, active 
and inactive 107 kDa protein, were compared by 
SDS-PAGE (fig.4A) no differences in size were 
detected. However, as shown in fig.4B when the 
two forms were analysed in non-denaturing, 11 Vo 
acrylamide gels lacking SDS, the active form clear- 
ly had a greater relative mobility, indicating an in- 
creased negative charge. Moreover, the inactive, 
107 kDa protein was relatively stable (fig.5), with 
I 
30 120 30 80 80 180 
TIME (min) 
Fig.5. Stability of the unmodified 107 kDa polypeptide 
in the culture medium. An exponentially growing culture 
of strain MC4100 (pLG583 + pLG575), grown in 
M9-glucose minimal medium at 37°C to &,o = 1 .O, was 
pulse-labelled with [35S]methionine (50,&i for 5 min) 
and chased with an excess of cold methionine in the 
presence of 250pg/ml chloramphenicol. The 107 kDa 
polypeptide (uppermost band) was precipitated at 
various times, and analysed by SDS-PAGE (11% 
acrylamide) followed by autoradiography (B). In A the 
amount of radioactivity in the 107 kDa band, 
determined by scanning the gel in B with an LKB 
Ultrascan (model 2202), is presented. Stability of the 
modified 107 kDa polypeptide is presented as a broken 
line. 
a half-life of 42 min, when pulse-chase ex- 
periments were carried out with MC4100 (pLG575 
+ pLG583). We have shown previously that the 
half-life of active haemolysin is maximally 25 min 
under these conditions [ 111. 
4. DISCUSSION 
The hlyC gene, together with the structural gene 
for haemolysin, h/yA are both required for the 
production of active haemolysin. However, we 
now show that the 20 kDa product of hlyC is not 
required for either the synthesis or the export of 
the 107 kDa, h/y_4 gene product, but is responsible 
for modification of the 107 kDa polypeptide which 
renders it haemolytic. This activation increases the 
mobility of the 107 kDa protein in non-denaturing 
gels and increases its sensitivity to proteolytic 
degradation. Preliminary results indicate that the 
modification of the 107 kDa polypeptide does not 
involve either glycosylation or phosphorylation of 
the protein. 
Previous findings that the haemolysin secreted 
by E. coli is the 107 kDa primary product of the 
h/yA gene [3,6] together with the present data that 
HlyC is not required for export of this polypeptide 
are quite inconsistent with previous models of 
haemolysin secretion [5]. Further studies, par- 
ticularly in regard to the nature and function of the 
hlyB and h/yD export functions are now essential 
to further understanding of the precise export 
mechanism. 
Comparison of the sequence of the hlyC gene of 
the human haemolytic determinant LE2001 with 
the hlyC gene encoded by the plasmid pHly152 of 
animal origin revealed 97% homology. These data 
confirmed previous indications that E. coli 
haemolysin determinants are strongly conserved 
[13] and that they have probably evolved from a 
common determinant. 
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